ArticleNeurology2026
Noninvasive Brain Stimulation in Translational Cognitive Neuroscience-Applications in Aphasia and Beyond: 2025 H. Houston Merritt Award Lecture.
Article in Neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Noninvasive brain stimulation (NIBS) has emerged as a transformative tool in both cognitive neuroscience research and the treatment of a growing range of neuropsychiatric conditions. This commentary, based on the 2025 H. Houston Merritt Lecture, explores how NIBS can be applied within a translational cognitive neuroscience framework that bridges theoretical models of cognitive function with targeted neural interventions. Drawing on over 15 years of research, the major focus of this piece is on the use of transcranial magnetic stimulation (TMS) to characterize and enhance language function in persons with aphasia (PWA). A significant body of work has examined the role of the right hemisphere, particularly the right pars triangularis, which may exert a maladaptive influence within reorganized language networks in many PWA. Inhibitory TMS targeting this region has been shown to produce both transient and sustained improvements in language performance. Key predictors of response to TMS include the characteristics of participants' language deficits and genetic differences that influence neuroplasticity. Network neuroscience approaches can also enhance predictive accuracy by revealing how individual variations in brain structure influence stimulation outcomes. While TMS remains the most extensively studied NIBS modality, transcranial electrical stimulation is gaining momentum, with promising results in both poststroke and primary progressive aphasia. Emerging modalities such as focused ultrasound and transcranial temporal interference stimulation are also on the rise as tools for enhancing brain performance. However, the expanding use of NIBS also raises ethical considerations that must be addressed to ensure its equitable and responsible deployment. Ultimately, NIBS represents a powerful convergence of neuroscience and technology, offering renewed hope for restoring cognitive function in individuals affected by neurologic disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.